News | Breast Imaging | April 06, 2018

ACR/SBI Breast Cancer Screening Guidelines Reclassify African-American Women as High-Risk

Guidelines assign special status and approach for African-American and other women at high risk for breast cancer

ACR/SBI Breast Cancer Screening Guidelines Reclassify African-American Women as High-Risk

April 6, 2018 — New American College of Radiology (ACR) and Society of Breast Imaging (SBI) breast cancer screening guidelines are the first to recognize that African-American women are at high-risk for the disease and should be screened as such. The ACR and SBI now call for all women to have a risk assessment at age 30 to see if screening earlier than age 40 is needed. The societies also newly-recommend that women previously diagnosed with breast cancer be screened with magnetic resonance imaging (MRI).

The ACR and SBI continue to recommend that women at average breast cancer risk begin screening at age 40.

“The latest scientific evidence overwhelmingly supports a continued general recommendation of starting annual screening at age 40. It also supports augmented and earlier screening for many women. These updates will help save more lives,” said Debra Monticciolo, M.D., FACR, chair of the American College of Radiology Breast Imaging Commission.

According to 2015 National Cancer Institute Surveillance, Epidemiology and End Results (SEER) data, since mammography became widespread in the 1980s, the U.S. breast cancer death rate in women has dropped 43 percent; it had been unchanged for the previous 50 years. Breast cancer deaths in men, who have the same treatment as women but are not screened, have not declined.

Factors that contributed to the ACR/SBI reclassification of African-American women include that:

  • African-American women are 42 percent more likely to die from breast cancer than non-Hispanic white women despite roughly equal incidence rates;
  • African-American women have a two-fold higher risk of aggressive — “triple-negative” — breast tumors;
  • African-American women are less likely to be diagnosed with stage I breast cancer, but twice as likely to die of early breast cancers; and
  • African-American women have a higher risk of BRCA1 and BRCA2 genetic mutations than those of Western European ancestry. These carriers are at much higher risk for breast cancer.

“Since 1990, breast cancer death rates dropped 23 percent in African-American women — approximately half that in whites. We changed our approach to help save more African-American women and others at higher risk from this deadly disease,” said Wendy B. DeMartini, M.D., FSBI.

For more information: www.endtheconfusion.org

Related Breast Imaging Content

ACR Recommends More Aggressive Breast Cancer Screening for Higher-Than-Average-Risk Women

 

Related Content

Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Feature | Breast Imaging | February 03, 2020 | By Barbara Smith
Women in the United States have a 1 in 8 (or about 13 percent) lifetime risk of being diagnosed with breast cancer du
ringing the cancer bell can do more harm than good, says an ASTRO study

Image courtesy of ASTRO

News | Radiation Oncology | January 27, 2020
January 27, 2020 — It's a scene that some cancer patients dream about: they celebrate the end of a course of radiatio
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...
Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
Virtual reality during chemotherapy has been shown to improve breast cancer patients’ quality of life during the most stressful treatments
News | Virtual and Augmented Reality | January 21, 2020
January 21, 2020 — Virtual reality during chemotherapy has been shown to improve...